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 Hostility positively correlates with MMP-2 activity in low social support. 
 Hostility explained up to a 28% of the variance of MMP-2 activity. 
 Social support was related with ejection fraction at acute myocardial infarction.   






















Psychosocial factors have been linked to cardiovascular diseases independently of traditional 
risk factors. The impact of psychosocial factors on plaque destabilizing factors, such as matrix 
metalloproteinases (MMPs) has been proposed although scarcely studied. 
Objective: to evaluate the relationships between hostility, perceived stress and social support 
with MMPs activity in patients after an Acute Myocardial Infarction (AMI). 
Methods: Blood samples were obtained from 76 patients on admission, post-angioplasty, 24 
hours, 7 days and 3 months after AMI. Hostility, perceived stress and social support were 
evaluated by validated questionnaires. 
Results: Social support was positively correlated with patients´ ejection fraction (r=0.453, 
p=0.009). Patients with higher infarct size presented increased MMP-2 activity at admission 
(p=0.04). Patients with one diseased vessel had more social support than those with three 
diseased vessels (p=0.05). The highest values of MMP-2 and MMP-9 activity were observed at 
the acute event, decreasing, with the lowest activity at 3 months post-AMI (p<0.001). Only in 
patients with low social support, hostility correlated with MMP-2 activity, from AMI onset 
(r=0.645, p=0.013), to 7 days post AMI (r=0.557, p=0.038). Hostility explained up to 28% of 
the variance in MMP-2 activity (R2=0.28, p=0.005). Finally, in patients with high hostility, 
MMP-9 was positivelycorrelated with IL-1β (r=0.468, p=0.02).  
Conclusions: this study adds weight to the idea that two psychosocial factors, namely hostility 
and social support, acting jointly, may affect MMP-2 activity. Moreover, in hostile patients, 
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there is a link between IL-1β and MMP-9. These findings support the role of psychosocial 
factors in plaque destabilization and in the inflammatory process in AMI. 
 





Cardiovascular diseases (CVD) and especially coronary heart disease (CHD) represents the leading 
cause of death in the world in both men and women (Alwan 2011). Traditional risk factors for CVD 
such as smoking, hypertension, diabetes and dyslipidemia have been widely studied, yet these factors 
do not predict all new CVD cases and often multiple risk factors combine in the onset of CVD (Wilson 
and Culleton 1998; Faletra et al 2009).  
Though the impact of psychosocial factors on CVD is more controversial, several meta-analyses of 
longitudinal studies have shown that a number of psychological characteristics including hostility, 
depression and job-stress have been linked to the onset of coronary artery disease (CAD) independent 
of traditional biomedical risk factors (Chida and Steptoe 2009; Kivimäki et al 2013). Several studies 
have found that hostility, reflecting angry feelings, cynical thoughts about others and antagonistic 
behavior (Barefoot et al, 1992), assessed by various methods, is predictive of future cardiovascular 
morbidity and mortality (Everson et al 1997). In a meta-analysis of prospective studies associating 
anger and hostility with future CHD, Chida and Steptoe (2009) found that high levels of anger and 
hostility were associated with not only increased CHD events in initially healthy populations, but also 
with poor prognosis in cardiac patients. Previous studies show that depression and hostility may 
interact to influence sympathetic (β-adrenergic) cardiac control and hemodynamic indices (Hawkins et 
al 2011). Moreover, different psychosocial factors could moderate the relationship between hostility 
and sympathetic hyperactivation or disease progression. For example, CAD patients with both high 
anger-out and low social support were found to have a higher risk of atherosclerosis progression, than 
other patients, reflecting a synergistic interaction between hostility and social support in relation to 
CAD (Angerer et al 2000). In another study, trait anger and social inhibition were associated with an 
increased prevalence and severity of coronary artery plaques (Compare et al 2014). Together, these 
results support the buffering hypothesis of social support, stress and health (Cohen and Wills, 1985) 
and extend them to social support’s moderating effect on hostility in relation to CAD.  
How can hostility and little social support act at the biological level to contribute to CAD? Based on 
converging empirical evidence, the impact of psychosocial factors on the onset of the acute coronary 
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syndrome (ACS) is thought to be due to their impact on inflammatory and plaque destabilizing factors, 
hemodynamic plaque rupturing forces (e.g., coronary spasms, elevated blood pressure) and thrombosis 
(Gidron et al 2002; Rozanski et al1999). One study found that life events, hostility and little social 
support were positively correlated with monocyte recruitment levels in ACS patients soon after 
admission (Gidron et al 2003). Pro-inflammatory cytokines such as IL-1 induce leukocyte 
chemoattraction to the endothelium, and activate plaque monocytes (macrophages). The macrophages 
then produce matrix matalloproteinases (MMPs) causing coronary plaque instability (Ross 1999). 
Atherosclerotic plaque rupture is a major cause of ACS (de Nooijer et al 2006). Several mechanisms 
such as matrix degradation have been implicated in this process and MMPs play an important role in 
plaque instability (Pasterkamp et al 2000; Newby 2008). Different MMPs, have been identified in 
atherosclerotic plaques and in regions of foam cell accumulation and have been directly associated 
with plaque remodeling as well as plaque vulnerability (Pasterkamp et al 2000; Newby  2008) and 
with myocardial remodeling (Dhillon et al 2009). Moreover, they have been suspected to be partly 
responsible for the pathogenesis of CAD (Ross 1999). Furthermore, levels of MMP-2 were found to 
be independent predictors of survival in patients after a myocardial infarction (Dhillon et al 2009). 
However, the role of psychosocial factor implicated in CAD, in elevation of MMPs, has received little 
scientific attention. It has been reported that psychosocial factors like hostility and depression are 
positively associated with MMP-9 levels (Lutgendorf et al 2008), and that sense of coherence (a 
resilience factor reflecting comprehensibility, manageability and meaningfulness), is associated with 
decreases in MMP-9, in a middle aged normal population (Garvin et al 2009). In contrast, Jönsson et 
al (2014) reported that there were no relationships between depressive mood and MMP-9 expression 
in patients after AMI. 
To our knowledge, the impact of psychosocial factors like hostility and social support on different 
MMPs activity has not been studied in ACS patients. Furthermore, it has been reported that social 
support may moderate the effects of stress on cardiac responses to stress (Gerin et al 1992). André-
Petersson et al (2007) found that social support moderated the effects of high demand and low control 
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(reflecting job strain) on future myocardial infarctions in women. However, it remains unknown 
whether social support may moderate the effects of adverse psychological factors such as hostility or 
stress on biological factors, which directly contribute to the onset of CAD and ACS.  
This study, through a prospective design, examined the relationships between hostility, perceived 
stress and social support with MMP-2 and MMP-9 activity, pro-inflammatory cytokines and 
hemodynamic factors in patients with ACS. We hypothesized that hostility and stress will be 
positively correlated with MMPs and inflammation, while social support would be inversely related to 
such outcomes. Finally, social support was expected to buffer (moderate) the effects of hostility and 
stress on such plaque-destabilizingfactors. 
2. Materials and Methods: 
 
The study population was comprised of 76 consecutive patients (64 men, 59±11 years and 12 women, 
61±15 years) who were hospitalized at the Argerich Hospital, Buenos Aires, with an ST-segment 
elevation acute myocardial infarction (STEMI), referred for primary angioplasty, within 24 hours of 
onset of symptoms. The STEMI was defined by prolonged chest pain and ST-segment elevation ≥ 
1mm in at least two consecutive leads, or a new or presumably new left branch bundle block.  
Full clinical details were recorded for all patients by pro-forma, including demographic data, smoking, 
coronary risk factors, previous clinical history and treatment as well as, educational level and marital 
status. Patients with cancer, stroke, and other severe inflammatory diseases and other pulmonary or 
hepatic diseases, endocrine disorders, thyroid disease, patients with Cushing's disease or syndrome, as 
well as chronic renal failure patients on hormonal treatment, were excluded from the subsequent 
analyses. We also excluded patients with cardiogenic shock at admission and other cardiovascular 
diseases. Previous myocardial infarction (MI) was established by evidence of previous hospital 
admission and a discharge diagnosis of MI (Thygesen et al 2012). All studies were performed in 
accordance with the Declaration of Helsinki, and all procedures were carried out with the adequate 
understanding and written informed consent obtained from all participants before coronary 
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angiography. The protocol was approved by the Ethics Committee of the Argerich Hospital and the 
Faculty of Pharmacy and Biochemistry, University of Buenos Aires. 
Coronary angiography and primary angioplasty were performed according to standard protocols and 
techniques. All the patients were referred to the catheterization laboratory, Hemodynamic Unit, within 
30 minutes after arriving at the Emergency Department, where they received 100 mg of aspirin, 300 
mg of clopidogrel and intravenous nitroglycerine.  
For each patient, the Killip and Kimbal index was evaluated at admission. The infarct size was 
established according to the territory threatened in accordance with the electrocardiographic 
compromise, so a large acute myocardial infarction (AMI) was considered when more than four 
electrocardiographic leads with grade 3 ischemia were involved (Birnbaumet al 2014). We used this 
technique as a surrogate marker of the cardiac magnetic resonance imaging (MRI).  The ejection 
fraction was calculated as: [(final diastolic volume – final systolic volume)/ final diastolic volume]. 
2.1 Biological tests: 
Samples: Blood samples were obtained on admission (time 1); during coronary angiography after 
angioplasty (time 2); the morning after the routine cardiac protocol, between 0800h-0900h(time 3); 7 
days after MI (time 4); and 3 months later (time 5). In each time period, serum and plasma samples 
were separated by centrifugation at 1500 × g for 5 min and stored at -70°C. Serum was used for 
cortisol, IL-1β, high sensitive CRP (hs-CRP), creatin kinase (CK), CK-MB determinations and MMP-
9 concentration, and plasma samples for MMP-2 and MMP-9 activity determination. 
Cortisol, IL-1β, hs-CRP, CK and MMP-9 determinations: Cortisol and IL-1β were determined by a 
chemoluminiscent method (Immuliteautoanalyzer 1, Siemens, LA, USA). The intra-assay (CVi) and 
inter-assay (CVe) variation coefficients for cortisol were <5% and <9.7% respectively and for IL-1β 
were <2.8% and <7.7%. Hs-CRP was measured by a high sensitivity immunoturbidimetric method 
(Roche Diagnostics, Mannheim, Germany) (CVi and CVe<3%), CK by UV-test (CVi<2.3%, 
CVe<3.3%) and CK-MB by UV-immunologic test (CVi<1.7% and CVe<8.1%) standard methods, in a 
Cobas C-501 autoanalyzer. MMP-9 concentration was determined by a solid phase ELISA assay 
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(Quantikine-ELISA, R&D Systems). The CVi was <2.0% and the CVe was <7.9%. Regarding the 
possibility that the acute event could mask possible associations between IL-1β and the other 
variables, IL-1β and MMP-9 concentrations were measured at time 4.  
MMP-2 and MMP-9 activity: MMP-2 and MMP-9 activity was measured in plasma by 
gelatinolyticzymography as previously described (Muzzio et al 2009). MMP-9 (84 kd [active form]) 
and MMP-2 (67 kd [active form]) were identified by molecular weight. Conditioned media from the 
promyelocyte U-937 cell line was used as activity standard. Coefficients of variation were 4.8% (CVi) 
and 8.6% (CVe). Enzyme activity was detected as colorless bands quantified using Scion-Image J 
software (Scion Corporation, Frederick, MD), and relative activity was expressed as a ratio to the 
internal standard. 
2.2 Psychological measures 
After angioplasty, when patients were in a lucid state, we assessed their hostility (Gidronet al 2001), 
perceived stress (Cohenet al 1988) and social support (Timmerman et al 2000) by validated 
questionnaires. The hostility and social support scales presented adequateinternal reliabilities with a 
Cronbach´s alpha of 0.740 and 0.827 respectively.However, the perceived stress questionnaire 
presented an unacceptably low Cronbach´s alpha of 0.166. Patients total scores for each scale were 
computed. 
2.3 Statistical analysis: 
We first tested the distribution of variables using normality tests (kurtosis and skewness). Spearman 
correlations were computed between independent and dependent variables and between potential 
confounders and dependent variables. To investigate the differences between groups we used the 
Mann-Whitney test. To verify differences within subjects among variables at different times, we used 
the Wilcoxon test.To examine the possible impact of psychosocial variables on MMPs we used 
Spearman correlations. We then divided the sample at the median, into high and low social support, as 
well as, high and low hostility to examine the possible moderating role of social support. A 
Spearman’s correlation controlling for different covariates (age, BMI, smoking, previous treatment 
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with aspirin and β-blockers and infarct size), and a linear regression analysis, were performed, to test 
the relationship between hostility and MMPs, separately in patients with low and high psychosocial 
factors, according to the median value. We tested the unstandardized residuals for normality in order 
to perform the regression analysis. 
 
3. Results: 
The characteristics of patients are presented in Table 1. As expected CK and CK-MB were higher in 
those patients with larger infarct size (p=0.019 and p=0.022, respectively). 
Median values of hostility, social support and perceived stress are shown in table 2. A positive 
correlation was observed between hostility scores and perceived stress (r=0.33 p=0.012). None of the 
three psychological variables were related to age, body mass index (BMI), waist circumference, or 
smoking status, nor were they related to common cardiovascular risk factors or medication status. 
Social support was positively correlated with patients´ ejection fraction (r=0.453, p=0.009). Finally, 
patients who had one diseased vessel reported higher levels of social support than those with three 
diseased vessels (17 (2-20) vs 14 (4-18), p=0.05). 
3.1 Cortisol and biomarkers of inflammation and vulnerable plaques: 
As seen in Table 3 cortisol, one of the stress hormones, was increased at admission, and decreased at 
24 hours. No correlation was found between cortisol, hostility, social support and perceived stress at 
any time (p=ns). 
Hs-CRP showed a significant increase at 24 hours and significantly decreased at 7 days after MI, 
reaching normal values at 3 months after angioplasty (Table 3). 
MMP-9 and MMP-2 activity presented the highest values at the acute event, showing a slow decrease 
with the lower activity at 3 months (Figure 1a and 1b). No correlation between MMP-9 concentration 




When patients were divided according to infarct size, those with larger infarct size presented increased 
MMP-2 activity at time 1 (RU: 1.04 (0.81-1.35) vs 0.96 (0.76-1.39), p= 0.04)) and increased MMP-9 
activity at time 4 (RU: 1.07 (0.88-1.25) vs 0.97 (0.77-1.18), p=0.05). Importantly, MMP-2 activity was 
inversely associated with the ejection fraction, at time 1 (r=-0.461, p=0.031), time 2 (r=-0.423, 
p=0.044), time 3 (r=-0.472, p=0.026) and time 4 (r=-0.429, p=0.046). Moreover, patients with higher 
degree of Killip and Kimbal index presented higher MMP-2 activity at time 1 (RU: 0.98 (0.76-1.39) vs 
1.04 (1.00-1.21), p=0.03). 
3.2 Association between psychosocial factors and MMPs over time 
There was no correlation between neither MMP-9 and MMP-2 activity nor MMP-9 concentration and 
the psychosocial factors at any time. However, when the studied population was split by the median 
value of social support, only in patients with low social support, hostility strongly and positively 
correlated with MMP-2 activity at time 1 (r=0.645, p=0.013); time 2 (r= 0.568, p=0.034); time 3 
(r=0.692, p=0.006) and time 4 (r=0.557, p=0.038), after controlling for age, BMI, smoking, previous 
treatment with aspirin and β-blockers and infarct size. Thereafter, a regression model was performed 
to evaluate the impact of hostility on MMP-2 activity in patients with low social support. Hostility 
explained 16% of the variance in MMP-2 activity after the AMI (F=4.75 p=0.038), 28% of the 
variance at 24 hours post-AMI (F=9.43 p=0.005) and 22% of the variance 7 days post-AMI (F=6.84 
p=0.015)  (Figure2) 
In the whole population, IL-1β(0.30 (0.13-0.67) pg/ml) tended to be significantly related to MMP-9 
concentration(611 (88-1787) ng/ml) at time 4 (r=0.266, p=0.078). We then split the studied population 
according to the median value of hostility, revealing a positive and significant association between IL-
1β and MMP-9 concentration (r=0.468, p=0.020) only in those patients with high hostility. These 
results remained significant after controlling for age, BMI, infarct size and previous treatment with β-





The current study examined the interplay between psychosocial variables and MMPs in ACS patients. 
Our results show that hostility positively correlates with circulating levels of MMP-2 activity in 
patients with low social support, but not in patients with high social support. It is notable that this 
association remained significant after statistically controlling for different confounders. Moreover, 
hostility explained up to 28% of the variance in MMP-2 activity in patients with low social support. 
Furthermore, in patients with high hostility, IL-1β was associated with MMP-9 concentration. Social 
support was positively correlated with ejection fraction soon after the acute event, and patients with 
more diseased vessels presented lower social support.  
MMPs play an important role in extracellular matrix (ECM) remodeling during all phases of 
atherosclerosis. Focal accumulation of cells that overexpress activated forms of MMPs may promote 
local destruction of ECM in atheroma, leading to plaque destabilization and rupture (Dollery et al 
1995). Increased peripheral blood levels of MMP-2 and MMP-9 were observed in patients with ACS 
(Kai et al 1998; Hlatky et al 2007). Moreover, Dhillon et al (2009) reported that MMP-2 levels were 
an independent predictor of mortality post-ACS in men and women. In the present study, we observed 
initially plasma MMP-2 and MMP-9 activity in ACS patients declining from 24 hours post-AMI. 
MMP-2 activity at the acute event inversely correlated with the ejection fraction and was associated 
with the surrogate estimation of infarct size and the Killip index. These results are in accordance to 
previous findings reported by Nilsson et al (2012) who observed positive  associations between MMP-
2 concentrations and infarct size evaluated by cardiac MRI. Moreover, in our study, MMP-9 activity 
was also positively correlated with infarct size. No correlation between MMP-9 concentration and 
activity was observed. This finding can be result of the fact that the activity of an enzyme is not 
necessarily related to its plasma concentration. 
Hostility and low social support are associated with worse lifestyle behaviors, including smoking, poor 
diet, obesity, and alcoholism (Bernstein et al 2014; Stickley et al 2014). It has been reported that 
hostile individuals may also manifest diminished vagal modulation of heart function and increased 
platelet reactivity, while low social support is associated with activation of the autonomic nervous 
system (Rozanskiet al 1999). In this study, we found that only in patients with low social support, 
hostility was positively associated with MMP-2 activity, independent of other risk factors. Previous 
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findings reported that negative psychosocial factors such as depression were positively correlated with 
enhance MMPs expression in ovarian carcinoma cells (Lutgendorf et al 2008). Moreover, previous 
results reported that hostility and depression were positively correlated with MMP-9 levels in middle 
age healthy people (Garvin et al 2009). It has also been proposed that a dysfunctional hypothalamic 
pituitary adrenal axis, a marker of chronic stress, promotes an increase in MMP-9 in patients with 
CAD (Szymanowski et al 2011). One possible mechanism involved in these relationships could be the 
link between psychological factors and the inflammatory response. Supporting this claim, we found a 
positive correlation between IL-1β and MMP-9, only in high-hostile patients, in the present study. 
Gidron et al (2003) reported in ACS patients that percentage of monocytes was positively correlated 
with adverse psychological characteristics, including hostility and life-events, while protective 
psychological factors, including perceived-control and emotional-support, were inversely correlated 
with percentage of monocytes. Pro-inflammatory cytokines, primarily secreted from monocytes, can 
induce vulnerable plaques through different pathways (Gidron et al 2003). In vitro and animal studies 
have identified the ability of cytokines to regulate the transcription and synthesis of various MMPs, 
specifically IL-1 which promotes ECM remodeling by enhancing cardiac fibroblast MMP expression 
in vitro (Berg et al 2011). Furthermore, hostility has been associated with higher production of pro-
inflammatory cytokines in women (Suarez et al 2004) and in men (Suarez et al 1998). Since hostility 
is also related to lower vagal modulation (Sloan et al 1994) and because the vagus has profound anti-
inflammatory effects (Tracey 2009), one mechanism linking hostility to high MMP levels (in patients 
with little social support) could include excessive inflammation via reduced vagal activity. Our results 
extend these to AMI patients, proposing that the synergism between hostility and low social-support is 
related to plaque-destabilizing factors. 
Different studies have reported an association observed between cortisol, as stress hormone, and 
psychological measures, at diverse situations (Evolahti et al 2006; Fabre et al 2014), however in the 
present study, no relationship among these parameters was observed. One possible explanation could 
be the acute response of the HPA axis soon after an ACS, which could mask the association. 
There are some limitations in this study. One limitation is that only one single measure of morning 
serum cortisol concentration was obtained 24 hours after AMI, which is not the optimal way to 
13 
 
evaluate links between HPA activity and cardiovascular disease. Nevertheless, it is a feasible approach 
for screening studies and has been previously applied (Weigensberg et al 2008; Gidron et al 2011; 
Fabre et al 2013). Furthermore, psychosocial variables were only assessed once, however, hostility is a 
stable psychological train not expected to change over short time periods. In addition, this study 
included a short follow up period of the patients as well as a relatively small sample size. Thus, these 
results should be replicated in a larger cohort of patients. Nevertheless, this study adds weight to the 
proposition that two psychosocial factors, namely hostility and little social support acting jointly, may 
affect MMP-2 activity, which has a major role in the pathogenesis of vulnerable plaques and in the 
acute coronary syndrome.  
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Figure 1: MMPs activity in the study population (n=76), from admission to 3 months post infarct. A) 
MMP-2p0.001 vs Admission; B) MMP-9 p0.001 vs Post Angioplasty. RU: Relative Units. 
Wilcoxon test. 
 
Figure 2: In the study population (n=76), hostility explained 16% of the variance in MMP-2 activity 
after the Acute Myocardial Infarction (AMI) (R2=0.16, p=0.038), 28% of the variance at 24 hours 





































Age (years) 59 (11.7) 
Male sex 64 (84.2%) 
Cardiovascular riskfactors   
Hypertension 41 (53.9%) 
Dyslipidemia 28 (36.8%) 
Diabetes mellitus 12 (15.8%) 
Smoking 41 (53.9%) 
Formersmokers 17 (22.4%) 
Obesity 29 (38.2%) 
Sedentarism 45 (59.2%) 
22 
 
Systolic blood pressure (mm Hg) 130.2 (22.8) 
Diastolic blood pressure (mm Hg) 77.7 (12.6) 
Heartrate (bpm) 79.5 (17.1) 
Weight (kg) 81.8 (14.8) 
Height (cm) 171.3 (8.3) 
BMI (kg/m2) 27.8 (4.4) 
Waistcircumference (cm) 97.7 (12.7) 
CK basal (U/L) 1379 (379 – 3012) 
CK peak (U/L) 2710 (1245 – 4082) 
CK-MB basal (U/L) 172.5 (67.5 – 307.5) 
CK-MB peak (U/L) 277 (167 – 490) 
Previoustreatment  
Aspirin 17 (22.4%) 
β-blockers 12 (15.8%) 
ACE inhibitor 16 (21.1%) 
Angiotensin II receptor antagonists 9 (11.8%) 
Calciumchannelblocker 4 (5.3%) 
Nitrates 3 (3.9%) 
Statins 6 (7.9%) 
Fibrates 1 (1.3%) 
Location of MI   
Anterior 33 (43.4%) 
Inferior 35 (46.0%) 
Lateral 4 (5.3%) 
Combined 4 (5.3%) 
Size of MI (established by location)  
Large (anterior orcombined) 37 (48.7%) 
Small (Inferior or lateral) 39 (51.3%) 
Killip and Kimbalclassification  
Killipclass I 61 (80.3%) 
Killipclass II 9 (11.8%) 
Killipclass III 6 (7.9%) 
Killipclass IV 0 (0%) 












Table 2:  Psychological factors evaluated in the study population (n=76).  
 
 
Table 3: Cortisol, hs-CRP, MMP-2 and MMP-9 at different times from admission (n=76). Median 
(range). 
 Cortisol (nmol/L) HS-CRP (mg/l) MMP-2 (RU) MMP-9 (RU) 
Admission 963 (193-1749) 4.58 (0.47-90.8) 0.99 (0.76-1.39) 1.02 (0.86-1.43) 
Post Angioplasty 1037 (195-1936) 4.30 (0.68-78.3) 0.98 (0.78-1.41) 1.05 (0.86-1.41) 
24 hours 386 (99.3-1749)* 17.4 (1.55-143)* 0.98 (0.75-1.47) 1.06 (0.91-1.39) 
7 days 411 (210-1010)* 15.3 (1.86-196)* 0.93 (0.71-1.26)* 1.00 (0.77-1.25)** 
3 months 345 (135-770)* 3.26 (0.38-30.0) 0.85 (0.58-1.14)* 0.99 (0.71-1.19)** 
RU: Relative Units. * p <0.001 vs Admission; ** p<0.001 vs Post Angioplasty, Wilcoxon test. 
 
 
Ejectionfraction (%) 43 (5-69)  
Number of diseasedvessels  
Onediseasedvessel 43 (56.1%) 
Twodiseasedvessels 25 (33.3%) 
Threediseasedvessels 8 (10.6%) 
 Perceived stress Hostility Social support 
Score, median (range) 
Patients below the median n (%) 
Patients above the median n (%) 
11 (5-15) 
43 (56.6%) 
33 (43.4%) 
16 (7-37) 
43 (56.6%) 
33 (43.4%) 
15 (2-20) 
38 (50%) 
38 (50%) 
24 
 
 
 
 
 
